Oya Yavuz
Nessuna posizione attualmente
Profilo
Oya Yavuz worked as Vice President of Investor Relations at Wolters Kluwer NV and as VP of Corporate Communications and Investor Relations at Crucell NV.
Precedenti posizioni note di Oya Yavuz
| Società | Posizione | Fine |
|---|---|---|
| WOLTERS KLUWER N.V. | Contatto Relazioni con gli Investitori | 01/06/2007 |
Crucell NV
 Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Contatto Relazioni con gli Investitori | - |
Esperienze
Posizioni ricoperte
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| WOLTERS KLUWER N.V. | Technology Services |
| Aziende private | 1 |
|---|---|
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Health Technology |
- Borsa valori
- Insiders
- Oya Yavuz
